Introduction
Failure of the cell to recognize and repair DNA damage frequently provides a key early step in tumor progression, as recently demonstrated by the discovery of the role of the postreplication mismatch repair genes in hereditary nonpolyposis colon cancer. Here, mutations in members of the mutS and mutL families of proteins that repair damage resulting from a variety of causes were shown to be directly linked to this disease (Fishel et al., 1993; Leach et al., 1993; Bronner et al., 1994; Nicolaideset al., 1994) . The introduction of damage into the DNA of higher eukaryotic cells leads to many events, including increased activities of p53 protein (Kastan et al., 1991) . This increase appears to orchestrate the activation of certain genes, including p21 /WAf 7 (El-Diery et al., 1993) , GADD45 (Kastan et al., 1992) , and mdm2 (Perry et al., 1993) , resulting in either growth arrest or apoptosis. Both the inhibition of DNA replication (Dutta et al., 1993) and a block at the Gl/S border (Martinez et al., 1991) allow time for the cell to repair its DNA or, under different circumstances, lead to an apoptotic pathway (Shaw et al., 1992; Yonish-Rovach et al., 1991; Wu and Levine, 1994) . Known classically as a tumor suppresser, p53 has been shown to be mutated in a large fraction of human tumor tissues and to be sequestered from its normal function by specific tumor virus proteins (Linzer and Levine, 1979; Lane and Crawford, 1979; Sarnow et al., 1982; Werness et al., 1990) . Together, these studies reveal a great deal about the role of p53 as a cell cycle checkpoint factor able to sense DNA damage. The precise link between lesions in DNA and the activation of ~53, however, has remained unclear.
Biochemically, ~53 can be divided into three major domains, a charged N-terminal portion (residues l-42), a central domain (residues 120-290) and a C-terminal domain (residues 310-390). The N-terminal region appears to be involved in transcriptional activation (Lin et al., 1994) , while the central domain confers sequence-specific DNA binding (Wang et al., 1993a (Wang et al., , 1994a Pavletich et al., 1993; Bargonetti et al., 1993) . Most of the mutants of ~53 in human tumors map to this central region. The C-terminal domain contains residues that confer on p53 the ability to oligomerize and to bind both single-stranded DNA (ssDNA) and RNA (Pavletich etal., 1993; Cloreet al., 1994; Wu et al., 1995) .
The ability of ~53 to bind to ends and single-stranded gaps in DNA has led to the suggestion that it may directly recognize damaged DNA since these structures frequently accompany exposure to irradiation or some mutagens. Further, electroporation of nucleases into cells has been shown to lead to increased levels of ~53 (Nelson and Kastan, 1994) . Many proteins, however, bind nonspecifically to ssDNA or to DNA ends, e.g., the yeast TATAbinding protein (Griffith et al., 1995) . The placement of p53 on a pathway involving signaling of damaged DNA has been strengthened by the discovery that GADD45, which is induced by ~53, interacts with the proliferating cell nuclear antigen, one of the proteins directly involved in DNA replication and repair and that is found associated with ERCC3, a transcription factor involved in nucleotide excision repair (Wang et al., 1994b) , and with replication protein A (RPA), a factor central to DNA replication and repair (Dutta et al,, 1993) . Indeed, both RPA and ERCC3 are part of a multifactor complex involved in human excision repair (reviewed by Sancar, 1994) .
It is possible that the induction of ~53 following irradiation and carcinogen exposure could reflect a response to both the initial lesions (e.g., thymine dimers and psoralen cross-links) and damage such as single base and insertion/deletion (IDL) mismatches (the latter also termed bulged or extra bases). IDL mismatches represent lesions in which there is one or more extra base on one strand of the DNA than on the other and can be either the result of polymerase-induced errors during replication or a secondary consequence of insult by irradiation or carcinogens. When lesions such as thymine dimers are introduced into DNA, translesion synthesis may insert a nucleotide(s) opposite the noninformational site, and this could leave behind mispairs and bulges (see Spivak and Hanawalt, 1992) . Single base and IDL mismatches are repaired by the mutHLS system in Escherichia coli (Modrich, 1991; Parker and Marinus, 1992) and an analogous system in yeast and higher eukaryotic cells (reviewed by Kolodner and Alani, 1994) , with mutS and its eukaryotic The location of one 3-cytosine (C3) or three 3-cytosine (3 C3) inserts on the top strand of the 45 bp DNA is illustrated as well as the loci of three G/T mismatches (3 G/T).
homologs MSH1 and MSH2 providing primary recognition of the lesions. Studying yeast, Kolodner and colleagues (Bishop and Kolodner, 1986; Muster-Nassal and Kolodner, 1986; Reenan and Kolodner, 1992) provided direct evidence both in vivo and in vitro of repair of single base and IDL mispairs in a PMS1-and MSH2-dependent fashion. Sites containing single base mismatches and single base IDL mismatches are also cleaved, although inefficently, by the human excision repair system (Huang et al., 1994) , illustrating the fact that there is likely overlap in lesion recognition by the different repair systems. Another E. coli protein, recA, also binds to DNA containing IDL mismatches and some single base mismatches (Wang et al., 1993b) . Indeed, a number of loose analogies can be drawn between p53 and recA. Both proteins catalyze the reannealing of complementary ssDNA (Cox and Lehman, 1981; Oberosler et al., 1993; Wu et al., 1995) , and p53 has been reported to catalyze strand transfer (Bakalkin et al., 1994) , a classic recA function. Further, irradiation of E. coli cells leads to the "activation" of recA and induction of the SOS response, making recA the key control element of a simple bacterial DNA damage signaling pathway. The knowledge that recA directly recognizes IDL mismatches led us to ask whether p53 might also bind to such lesions in DNA. In this report we present evidence from electron microscopy (EM) and gel retardation studies showing that both p53 and its 14 kDa C-terminal domain recognize and bind tightly to IDL mismatches, in both cases predominantly as tetramers. The complexes formed at the lesions are highly stable, unlike complexes formed with DNA containing only free ends. Several functions for such highly stable complexes are discussed.
Results
Visualization of p53 Binding to DNA Containing IDL Mismatches DNAs 1.1 kb in length with central lesions were constructed to probe the binding of p53 to single base or IDL mismatches. DNA cassettes 45 bp long containing 4-base AGCC 3' overhangs were synthesized and mixed with a 538 bp DNA fragment containing one blunt end and one end with a GGCT 3' overhang resulting from Banll cleavage. Under conditions inhibiting blunt-ended joining, the only ligation product was a 1129 bp DNA consisting of a single central cassette flanked by two 538 bp arms (see Experimental Procedures). This strategy takes advantage of the nonsymmetric cleavage sequence of Banil. The cassettes contained no lesion, three G/I" mismatches spaced by 3 bp, a 3-cytosine bulge in the top strand, or three such 3-cytosine bulges, spaced by 3 bp (Figure 1) . Design of the triple lesions was based on the work of Alani et al. (1995) showing that such defects provide strong recognition signals for yeast MSH2. The three 3-cytosine bulges were chosen based on data from filter binding (data not shown) indicating that cytosine bulges provided stronger signals than adenine bulges.
Human p53 (produced in insect cells) was incubated with the 1.1 kb DNA for 30 min at room temperature followed by fixation with 0.6% (p53) or 0.001% (C-terminal domain) glutaraldehyde. The samples were filtered through Biogel A5M to remove the free protein and fixatives and were prepared for EM by a method involving air-drying and rotary shadowcasting with tungsten (see Experimental Procedures). The incubations contained p53 or the C-terminal fragment at molar ratios varying from three to five protein tetramers per DNA.
When we examined fields of complexes formed between p53 and the 1.1 kb DNA containing either a 3-cytosine IDL mismatch or three such mismatches at the center, large numbers of DNAs were found to be present with an easily observed, centrally located protein complex (Figure 2 ). By scoring fields of molecules (from an incubation with three tetramers per DNA that contained three IDL mismatches), we observed that 22% contained a protein complex bound at the exact center of the DNA, 58% of the DNA appeared protein free, 12% contained a protein complex at one or both ends, and 8% contained a protein complex internal to an end but not at the center (n = 200). When the DNA contained a single 3-cytosine IDL mismatch, the fraction of DNA molecules with p53 bound at the center was 14%, as contrasted with 22%. Frequently, the DNA appeared highly bent about the p53 complex; however, since a 3-base IDL mismatch will bend DNA by nearly 90 ° (Wang et al., 1992) , the lesion itself likely contributed significantly to the bending. Indeed, inspection of the DNA with one or three 3-cytosine IDL mismatches in the absence of p53 showed that nearly half were highly kinked at the center. Nonetheless, p53 may contribute to the bending since analysis of the bending of the MCK promoter showed that p53 tetramers bent the DNA by up to 75 ° (S. L. and J. G., unpublished data).
When the 1.1 kb DNA containing three G/T mismatches spaced by 3 bp was incubated with p53 as described above and was examined by EM, no significant binding to the site of the mismatches was observed. However, G/T mismatches are not recognized by recA protein (Wang et al., 1993b) , and mutS protein recognizes some single base mismatches much more efficiently than others (Modrich, 1991); thus, it cannot be concluded from this single observation that p53 does not in general recognize single base mismatches.
The protein complexes bound at the site of the IDL mismatch fell into three size groups. The first (shown in Figure Figure 2 . Visualization of p53 Bound to DNA Containing IDL Mismatches Human p53 was incubated with a 1129 bp DNA containing either one or three 3-cytosine IDL mismatches at the center. The complexes were prepared for EM by mounting them onto thin carbon foils, air-drying, and rotary shadowcasting with tungsten (see Experimental Procedures). Presumptive p53 dimers (a), tetramers (b-d), and higher oligomers (e) are at the site of the lesion. An end-bound complex is shown in (f). These images are shown in reverse contrast. Insets show the protein complex at higher magnification. The scale bar equals 0.1 p_m (lower magnifications). 2a) consisted of roughly spherical particles whose size was only marginally larger than tetramers of E. coli SSB (for single-strand binding) protein (76 kDa) prepared and shadowcast at the same time on separate grids. These p53 particles were most likely dimers, but may have included some monomers. The second class of particles that were the most abundant (Figures 2b-2d) were significantly larger than the SSB tetramers and had a distinct squareshaped projection, and often one could distinguish three or four subdomains. These particles were most certainly p53 tetramers. Finally, larger elongated particles or short filaments ( Figure 2e ) were present that must consist of several p53 tetramers. In scoring p53 complexes bound at the site of the lesion, we found that 29% of the DNA was scored as containing p53 monomers or dimers, 35% contained p53 tetramers, and 36% had higher oligomers of bound p53 (n = 228). p53 was also observed bound to DNA ends (Figure 21' ). Occasionally, circles were noted, generated either by p53 binding to the ends of a linear DNA and then interacting with itself or possibly by a single complex at one end capturing a second free DNA end.
Visualization of the 14 kDa p53 C-Terminal Domain Binding to DNA Containing IDL Mismatches
The 14 kDa p53 C-terminal fragment (residues 311-393; see Experimental Procedures) was incubated with the IDL mismatch-containing DNAs, as described above, and prepared for EM using three to five protein tetramers per DNA fragment. Examination of fields of DNAs revealed a large fraction with a protein complex at its center (Figure 3) .
Here, the protein complexes were much smaller than those observed with full-length p53. Using these EM methods, a protein with a mass of 14 kDa would not be expected to be visibly bound to DNA, a protein of 28 kDa would be at the edge of detection, as shown recently in a study of the 28 kDa yeast TATA-binding protein (Griffith et al., 1995) , and a 56 kDa protein would be small but easily observed. Thus, the predominant C-terminal complexes are likely tetramers, and indeed some appeared tetrameric (insets in Figures 3c and 3d) . When E. coli SSB tetramers (76 kDa) were added to the C-terminal complexes and the projected area of the complex compared with that of SSB tetramers in the background, the C-terminal complexes had an average area of 0.86 times that of the SSB tetramers. Conversion from an area to a volume ratio (multiplication by a power of 3•2) and multiplication by the mass of the SSB tetramer revealed that the C-terminal fragment-DNA complexes had a mass of 60 _ 17 kDa (n = 13), supporting the idea that these complexes were tetramers.
When fields of molecules were scored in which the C-terminal fragment was incubated at a molar ratio of three protein tetramers per DNA fragment (containing three 3-cytosine IDL mismatches), 37% had a protein complex at the center of the DNA, 50% of the DNA showed no visibly bound protein, 7% had a protein complex at one or both ends, and 6% of the DNA had a single protein complex bound internally but not at the center (n = 200). Only a few percent of the moleculeswith a protein complex at the lesion also showed protein bound either at an end or elsewhere on the DNA.
The C-terminal domain of p53 confers the ability to anneal ssDNA (Wu et al., 1995) . One explanation for the Complexes were formed between the p53 C-terminal fragment (residues 311-393) and the 1129 bp DNA containing three 3-cytosine IDL mismatches at the center and were prepared for EM as described in Figure 2 . Insets show the protein complex at higher magnification. The scale bar equals 0.1 I~m (lower magnifications).
results described above is that p53 and its C-terminal fragment are merely recognizing single-stranded character in these lesions. If so, then classic single-stranded binding proteins that have very high affinity for ssDNA, such as SSB, T4 gene 32 protein, or yeast RPA, should show an even higher binding than p53. To examine this, we incubated the IDL mismatch-containing DNAs with each protein at a molar ratio of 20 or 12 protein monomers per DNA fragment (containing either one or three IDL mismatches, respectively). Fields of molecules were scored for the fraction of DNA with a protein complex at the center. The results (Figure 4) show that while a large fraction of the lesions were targeted by p53 or its C-terminal domain, only a low background level of binding was observed with SSB, g32p, or yeast RPA, and most of these proteins showed binding to the DNA ends and not internally. Thus, p53 is recognizing a more subtle feature of these lesions than single-stranded character. Indeed, as noted in filter binding studies (data not shown), p53 bound better to 3-base than 4-base cytosine bulges, yet the extra bases would be expected to be more exposed in the 4-base than the 3-base bulge.
Gel Retardation Analysis of the Binding of p53 and Its C-Terminal Domain to DNA Containing IDL Mismatches
Gel retardation assays were utilized to obtain an independent quantitative measure of p53 and its C-terminal fragment binding to DNA containing IDL mismatches. Here, DNAs 49 bp long were synthesized with the same sequences as those shown in Figure 1 , but with flush ends. The DNA was labeled with 32p, and 1 ng was incubated with increasing amounts of p53 (see Experimental Procedures) for 20 min at room temperature and then electrophoresed on polyacrylamide gels. When the DNA contained no lesion, faint retarded bands due to the formation of a p53-DNA complex could be seen with the higher levels of p53 ( Figure 5A, lanes 3 and 4) . When the DNA contained either one or three 3-cytosine bulges ( Figure 5A, lanes 5-12) , a very distinct series of retarded bands was observed even with the lowest amount of p53 added in the incubations.
Based on EM observations, we assume that this distinct series of bands includes p53 bound to DNA ends and p53 monomers, dimers, tetramers, and possibly higher oligomers bound at the lesion. Quantiation of the amount of DNA in the retarded lanes ( Figure 5B) showed that with 24 nM p53, 40% of the total lesion-containing DNA was retarded, while less than 5% was retarded with the lesionfree DNA. To determine whether the C-terminal fragment would show binding in these assays, we incubated the same DNAs with full-length p53 ( Figure 5C , lanes 4-6) or with the 14 kDa C-terminal fragment (lanes 7-9). As shown in Figure 5 , retarded bands were observed with both lesion-containing DNAs and with both p53 forms, with the mobility of the retarded bands being higher with the C-ter- Figure 4. Classic ssDNA-Binding Proteins Do Not Recognize IDL Mismatches Three proteins with high affinity for ssDNA (E. coil SSB, T4 gene 32 protein, and yeast RPA) were incubated with the 1.1 kb DNAs containing either one 3-cytosine IDL mismatch (~3) or three such mismatches (3-C3) and prepared for EM as described in Figure 2 . Fields of molecules were scored for the fraction containing a protein complex at the lesion. Molar ratios of 20 and 12 protein monomers per DNA were used for the one 3-cytosine IDL mismatch and the three 3-cytosine IDL mismatch DNAs, respectively. -4) , a single 3-cytosine bulge (lanes 5-8), or three 3-cytosine bulges (lanes 9-12) was carried out by incubating the DNAs with no p53 (lanes 1, 5, and 9), 6 nM p53 (lanes 2, 6, and 10), 12 nM p53 (lanes 3, 7, and 11), or 24 nM p53 (lanes 4, 8, and 12) for 20 min at room temperature, followed by electrophoresis on polyacrylamide gels (see Experimental Procedures).
(B) The fraction of DNA shifted in each band in (A) was quantitated: no p53 (Con), one 3-cytosine bulge (C3), or three 3-cytosine bulges (3C3).
(C) The DNA lacking the lesion (lanes 1, 4, and 7), with a 3-cytosine bulge (lanes 2, 5, and 8), or with three 3-cytosine bulges (lanes 3, 6, and 9) was incubated with no p53 (lanes 1-3) , with full-length p53 (lanes 4-6), or with the 14 kDa C-terminal fragment (lanes 7-9).
minal fragment as expected. Here, two shifted bands were observed that may correspond to dimers and tetramers or the C-terminal fragment bound to the lesion. Gel retardation assays coupled with the addition of competitor DNA provide a means of examining the stability of DNA-protein complexes• Here, the radiolabeled DNAs described above were incubated with p53 ( Figure 5A ; 1 ng of DNA; 25 ng of p53) at room temperature for 20 min, followed by the addition of increasing amounts of unlabeled DNA for an additional 20 min. The sample was then electrophoresed on polyacrylamide gels, the position of the radiolabeled DNA determined by phosophorimaging, and the amount of DNA in each band determined (see Experimental Procedures). As shown in Figures 6A and -4) , one 3-cytosine bulge (lanes 5-8), or three 3-cytosine bulges (lanes 9-12) were incubated with 12 nM p53 for 20 min at room temperature, and then increasing amounts of the same sequence DNA (lacking lesions and not labeled) were added for an additional 20 min before electrophoresis on polyacrylamide gels. Amounts of added competitor were 0 ng (lanes 1,5, and g), 50 ng (lanes 2, 6, and 10), 100 ng (lanes 3, 7, and 11), or 200 ng (lanes 4, 8, and 12).
(B) The amount of total DNA shifted into the retarded bands was measured and plotted• A clear biphasic response to challenge by the competitor is seen for the DNA with one 3-cytosine bulge (C3) or three 3-cytosine bulges (3C3), but not for the DNA lacking the bulges (Con)• (C) The experiment in (A) was repeated using 75 ng of cold competitor DNA, but the time of incubation with the competitor varied from 0 min (lanes 1-3), 20 min (lanes 4-6), and 120 rain (lanes 7-9) to 17 hr (lanes 10-12). The DNAs contained no lesion (lanes 1, 4, 7, and 10), one 3-cytosine bulge (lanes 2, 5, 8, and 11), or three 3-cytosine bulges (lanes 3, 6, 9, and 12).
6B, while none of the complexes formed on the DNA lacking lesions was resistant to the added competitor, -4 5 % and -40% of the complexes with three and one 3-cytosine bulges, respectively, were resistant to a 200-fold excess of competitor DNA. To examine further the stability of these complexes, incubations as shown in Figure 6A , using the DNA with three 3-cytosine bulges (and 75 ng of competitor) and four incubation times in the presence of competitor (0 min, 20 min, 120 min, and 17 hr), were tested. As shown in Figure 6C , in agreement with the previous experiment, roughly half of the complexes decayed rapidly, but then little change was seen between 20 min and 120 min, and the complexes disappeared only after a 17 hr incubation. This suggests that the stable complexes have a half-life of >2 hr, and similarities with work on MSH2 are discussed below.
Discussion
The experiments presented here demonstrate that p53 and its C-terminal domain recognize sites on DNA containing IDL mismatches, a common form of primary DNA damage. Excellent concordance of the results obtained by two very different methods, EM and gel retardation, was observed, and our EM observations are in general agreement with those of Stenger et al. (1994) , who examined p53 binding to a p53 response element by EM and observed p53 tetramers bound to DNA. In our EM studies, p53 and its C-terminal domain were seen to bind selectively to a site containing one or three 3-cytosine IDL mismatches in a 1.1 kb DNA, binding predominantly as protein tetramers. EM showed that these lesions were not recognized by the classic ssDNA-binding proteins, allowing us to argue that p53 detected the lesion and not single-stranded character. Gel retardation assays in which increasing amounts of competitor DNA were added revealed that two types of complexes were formed on the DNA: unstable ones that were also seen with DNAs lacking lesions but containing free ends, and highly stable complexes that required the presence of an IDL mismatch. Support for the biological relevance of in vitro studies characterizing proteins that bind mispairs and IDL mismatches comes from work in yeast, where it has been shown that the substrate specificity in vitro for MSH1 and MSH2 parallels the repair efficiency in vivo (Bishop and Kolodner, 1986; Chi and Kolodner, 1994; Alani et al., 1994;  for detailed review see Alani et al., 1995) . Indeed, it is instructive to compare our results with studies of MSH2 by Fishelet al. (1994) and Alani et al. (1995) . There, using gel retardation and filter binding assays, it has been observed that yeast and human MSH2 shows only a modest selectivity for mispaired bases but has a high affinity for IDL mismatches, with the affinityincreasing as the number of extra bases in the bulge increases. In the work of Alani et al. (1995) , two kinds of complexes were detected: unstable complexes formed when MSH2 bound to homoduplex DNA, and highly stable ones formed when the latter complex encountered mismatched bases. The stable complexes were resistant to challenge by excess competitor, leading Alani et al. (1995) to propose that MSH2 undergoes a conformational change when it forms a stable complex at the lesion. They further suggest that the stable complex serves as a recognition signal for interaction with proteins involved in subsequent steps. Here, we observed only background binding of p53 at the site of a G/T mismatch, strong binding to a 3-base bulge, even stronger binding with three closely spaced bulges, and stronger binding yet to a single bulge containing four CA repeats (data not shown). Further, when p53 was incubated with DNA lacking lesions, binding was rapidly eliminated by the addition of competitor DNA, but when the DNAs contained bulges, 40%-45% of the complexes resisted challenge by a 200-fold excess of competitor, arguing for the presence of unstable and highly stable complexes like those seen with MSH2. Finally, using similar approaches to those of Alani et al. (1995) , who reported a half-life of at least 8 hr for the stable MSH2 complexes, we observed that the stable p53 complexes had a half-life of at least 2 hr and possbily considerably more. Based on these comparisons, we would suggest that, like MSH2, p53 forms initially unstable complexes that then become highly stable complexes upon encountering IDL misrn'atches.
The formation of highly stable complexes on DNA could reflect, among other things, a higher inherent affinity for deformations or lesions in DNA than for DNA ends or, as suggested by Alani et al. (1995) for MSH2, a conformational change in the protein that occurs upon binding to the lesion. Our present data do not allow us to distinguish among the several possibilities. However, the finding that lesion binding is mediated by the C-terminal domain, combined with the work of others (Hupp et al., 1992; Bayle et al., 1995) that showed that the C-terminal domain also regulates binding of the central domain, suggests that the C-terminal and central domains communicate to facilitate DNA binding. This is supported by the observation that binding of duplex DNA at the C-terminal domain significantly reduces the ability of the central domain of p53 to bind to sequence-specific sites inDNA (Bayle et al,, 1995) . Further, L. Jayaraman and C. Prives (personal communication) recently observed that short (but not long) ssDNA fragments of the size removed by the human excision repair system stimulate the ability of p53 to bind to the GADD45 response element in supertwisted DNA. Finally, based on their recent X-ray structure of the p53 tetramerization domain, Jeffrey et al. (1995) raised the possibility that the C-terminal portion of p53 could modulate the sequence-specific binding activity.
There are numerous biological ramifications for very stable p53 complexes formed at lesions in DNA. The half-life of p53 in vivo is short owing to rapid protease degradation (Chowdary et al., 1994) . Following irradiation or exposure to mutagens, p53 shows an accumulation in the nucleus and increased activity owing, it is believed, to an increased half-life (Kastan et al., 1991; Nelson and Kastan, 1994; Price and Calderwood, 1993; Tishler et al., 1993) , likely reflecting an increase in protease resistance. This might occur if, upon binding DNA at the site of a lesion, a conformational change were to hide protease sensitive sites. A highly stable p53 complex at the site of a lesion could provide a scaffold for the assembly of multiprotein complexes engaged in DNA repair and could enhance the ability of p53 to activate specific genes involved in cell cycle control, apoptosis, or DNA damageresponse.
Experimental Procedures

DNA Templates
Oligonucleotides of 49 bases were synthesized on an Applied Biosysterns 380B DNA synthesizer, deprotected, purified on 12% urea gels, annealed to produce the 45 bp cassettes with 4 nt 3' overhangs, and finally electrophoresed on 10% nondenaturing polyacrylamide gels to remove any ssDNA. The duplex arms were prepared by PCR amplification (Perkin-Elmer thermocycler) using primers that amplified a 640 bp segment in pBR322 DNA containing a single Banll site. This DNA was digested with Banll endonuclease, and the 538 bp fragment containing one blunt end and one end with a GGCT 3' overhang was separated by electrophoresis on a 1.2% agarose gel. The 538 bp DNA arms were ligated to the 45 bp cassettes (Figure 1 ) at room temperature for 2 hr. The final product (1129 bp) was purified from 1.2% agarose gels.
For gel retardation assays, 49 bp duplexes containing either no mismatch, a single 3-cytosine bulge at the center, or three such bulges at the center were prepared by annealing 49 nt oligonucleotides synthesized as above to produce duplex DNAs with blunt ends.
Proteins p53 protein and the C-terminal fragment were purified as described by Wu et al. (1995) . E. coil SSB protein was prepared as described by Chase et al. (1980) . T4 phage gene 32 protein was the gift of W. Konigsberg (Yale University). Yeast RPA protein was the gift of R. Kolodner (Harvard University). Restriction endonucleases, T4 DNA ligase, and T4 DNA kinase were from New England Biolabs and were used according to the specifications of the manufacturer.
EM
Complexes of p53 or its C-terminal fragment and DNA were formed by incubating 100 ng of DNA in 50 p.I of 10 mM HEPES (pH 7.5), 100 mM NaCI buffer for 20 min at room temperature using the amounts of protein indicated in the text. The DNA-protein complexes were then prepared for EM by fixation with 0.6°/0 (p53) or 0.001o/0 (C-terminal fragment) glutaraldehyde for 10 min at room temperature, followed by filtration through 2 ml columns of Biogel A5M (Bio-Rad). The filtered samples were mixed with a buffer containing 2 mM spermidine, 0.15 M NaCI and applied for 30 s to thin carbon foils supported by 400 mesh copper grids. The grids were washed with sequential washes of water and graded ethanol series, air-dried, and rotary shadowcast at 10 .7 torr with tungsten (Griffith and Christiansen, 1978) . Samples were examined in a Philips CM12. To estimate the mass of DNAprotein complexes, we measured the projected areas of images on 35 mm film using a Sony CCD camera and the NIH IMAGE software.
Gel Retardation Assays
For gel retardation assays, blunt-ended 49 bp DNA duplexes (Figure 1 ; DNA templates as described above) purified from 100/0 nondenaturing polyacrylamide gels were labeled with [32P]rATP using T4 DNA kinase and then passed through G50 spin columns. Details of amounts of DNA, incubation temperature, and time appear in the text and figure legends. Amounts of DNA based on adding the same amount of radioactivity were mixed with loading dye and electrophoresed on 3.5% polyacrylamide gels (19:1 acrylamide:bisacrylamide) at 200-300 V at room temperature in 0.5x TBE buffer until the unbound DNAs migrated close to the bottom of the gel. The position of the DNA was visualized by a Molecular Dynamics phosphorimager. Binding buffer for the gel shift experiments with the C-terminal fragment was the same as in the EM studies, but with full-length p53, a buffer containing 100 mM NaCI, 10 mM HEPES (pH 7.5), 10% glycerol, 100 p.g/ml BSA, 0.5 mM DTT, and 0.025% NP-40 was utilized to aid in stabilizing p53 at the low protein concentrations. The protein was stored at -70°C, and freezing and thawing were avoided as much as possible.
